Swedish Transportation Stock News

OM:LOOMIS
OM:LOOMISCommercial Services

Top European Dividend Stocks To Watch In February 2026

As the eurozone economy continues its modest recovery with strengthened confidence and investment, European markets have shown resilience despite mixed performances among major stock indexes. In this environment, dividend stocks can offer investors a potential source of steady income and stability, making them an attractive option to consider as part of a diversified portfolio.
OM:ANOD B
OM:ANOD BIT

Addnode Group (OM:ANOD B) Margin Improvement Reinforces Bullish Profitability Narratives

Addnode Group (OM:ANOD B) has wrapped up FY 2025 with fourth quarter revenue of SEK 1,564 million and basic EPS of 1.01 SEK, alongside trailing twelve month revenue of SEK 5,793 million and EPS of 2.87 SEK that frame the latest print in a wider context. The company has seen quarterly revenue move between SEK 1,311 million and SEK 1,564 million over the year, while quarterly EPS ranged from 0.40 SEK to 1.01 SEK. This gives investors a clear read on how the top and bottom line have tracked...
OM:SKF B
OM:SKF BMachinery

Do SKF’s Softer Q4 Earnings and SEK 7.75 Dividend Reveal a Strategic Shift for (OM:SKF B)?

AB SKF (publ) recently reported fourth-quarter 2025 results showing sales of SEK 21,969 million and net income of SEK 568 million, while also guiding for a currency impact of around SEK 800 million on first-quarter 2026 operating profit based on exchange rates as of December 31, 2025. At the same time, the company’s Board proposed a dividend of SEK 7.75 per share in two instalments and announced that Board member Susanna Schneeberger will not stand for re-election at the 2026 Annual General...
OM:BOL
OM:BOLMetals and Mining

Boliden (OM:BOL) EPS Surge Tests Bearish Narrative On Earnings Durability

Boliden (OM:BOL) has just wrapped up FY 2025 with fourth quarter revenue of SEK28.1b and basic EPS of SEK15.31, while trailing twelve month revenue sits at SEK93.5b with EPS of SEK33.39, setting a clear earnings-season marker for investors. Over the last few reporting periods the company has seen revenue move from SEK25.8b in Q4 2024 to SEK28.1b in Q4 2025 and basic EPS shift from SEK10.95 to SEK15.31, with trailing net profit margin easing from 11.2% to 10.1%. The latest numbers put the...
OM:HM B
OM:HM BSpecialty Retail

A Look At H & M Hennes & Mauritz (OM:HM B) Valuation After Earnings Dividend Hike And Completed Buyback

Why this cluster of news matters for H & M Hennes & Mauritz (OM:HM B) H & M Hennes & Mauritz (OM:HM B) just wrapped up a busy update, combining full year 2025 results, fresh sales guidance, a higher proposed dividend, and confirmation that its latest share buyback programme is complete. For the year to 30 November 2025, the company reported sales of SEK 228,285 million compared with SEK 234,478 million in the previous year, while net income was SEK 12,158 million compared with SEK 11,621...
OM:PNDX B
OM:PNDX BReal Estate

Did Pandox’s (OM:PNDX B) Crowne Plaza Antwerp Sale Quietly Redefine Its Leasing-Led Strategy?

Pandox has completed the sale of the Crowne Plaza Antwerp hotel in Belgium, including property and operations, for approximately €19 million, removing a 262-room asset that generated about €11 million in 2024 revenue from its portfolio. This exit from an Own Operations asset underscores Pandox’s ongoing effort to reshape its portfolio and place greater emphasis on core holdings and leasing-oriented income. We’ll now explore how this hotel divestment, and the shift toward a more...
OM:EQL
OM:EQLHealthcare

Margin Compression At EQL Pharma (OM:EQL) Challenges Defensive Generics Narrative

Latest Quarter Sets the Stage for EQL Pharma’s Next Chapter EQL Pharma (OM:EQL) just posted Q3 2026 revenue of 118.9 million SEK with basic EPS of 0.33 SEK, alongside trailing twelve month EPS of 1.00 SEK on 425.8 million SEK of revenue. These figures put fresh numbers behind the recent share price of 61.5 SEK. The company has seen quarterly revenue move from 92.2 million SEK in Q3 2025 to 118.9 million SEK in Q3 2026, while basic EPS shifted from 0.35 SEK to 0.33 SEK over the same periods...
OM:ALFA
OM:ALFAMachinery

Alfa Laval (OM:ALFA) Margin Improvement Reinforces Bullish Profitability Narratives

Alfa Laval (OM:ALFA) just wrapped up FY 2025 with fourth quarter revenue of SEK19.1b and basic EPS of SEK4.79, alongside trailing twelve month revenue of SEK69.7b and EPS of SEK20.01. Over the past two reported fourth quarters, revenue moved from SEK18.3b to SEK19.1b and quarterly EPS shifted from SEK4.96 to SEK4.79, while trailing net profit margin sits at 11.9% compared with 11.0% a year earlier. This gives a clearer view of how profit is tracking against sales. With that mix of higher...
OM:LIFCO B
OM:LIFCO BIndustrials

Lifco (OM:LIFCO B) Valuation Check As Higher 2025 Dividend Proposal Follows Strong Full Year Earnings

Lifco (OM:LIFCO B) is back in focus after the board proposed a higher dividend of SEK 2.70 per share for 2025, alongside full year 2025 results showing higher sales and net income. See our latest analysis for Lifco. Despite the stronger full year 2025 figures and the higher proposed dividend, Lifco’s recent share price return has been mixed, with a 1-day share price return of 0.64% and a 7-day share price return of 1.35%, set against a 30-day share price return decline of 6.06% and a 90-day...
OM:ESSITY B
OM:ESSITY BHousehold Products

Essity Expands North American Feminine Care Footprint With Edgewell Deal

Essity has completed the acquisition of Edgewell Personal Care’s feminine care business. The deal adds brands such as Carefree, Stayfree, o.b., and Playtex to Essity’s portfolio in North America. The transaction strengthens Essity’s position in the high margin feminine hygiene segment in the U.S. and wider North American market. Essity, traded as OM:ESSITY B, is leaning further into personal care categories that carry higher margins, with a current share price of SEK273.8. The company is...
OM:VITR
OM:VITRBiotechs

Vitrolife (OM:VITR) Is Down 24.1% After Impairment-Driven Loss And Maintained Dividend Proposal Has The Bull Case Changed?

Vitrolife AB reported fourth-quarter 2025 sales of SEK 891 million and a full-year net loss of SEK 5,012 million, while its Board proposed an unchanged dividend of SEK 1.10 per share for approval at the upcoming Annual General Meeting. The sharp swing from prior-year profit to a very large loss, driven by impairment and restructuring costs, contrasts with continued organic sales growth and a maintained dividend proposal. We’ll now examine how the large impairment-driven loss, alongside...
OM:MYCR
OM:MYCRElectronic

Mycronic (OM:MYCR) Valuation Check After New MMX Metrology Order In Asian Semiconductor Market

Mycronic (OM:MYCR) has secured a new MMX metrology system order in Asia, valued between US$2 million and US$4 million, with delivery scheduled this quarter. The order reinforces the company’s push into semiconductor related equipment. See our latest analysis for Mycronic. At a share price of SEK207.65, Mycronic’s recent MMX order comes against a backdrop of softer short term share price returns, including a 1-month share price return decline of 4.13%, while its 3-year total shareholder return...
OM:SCA B
OM:SCA BForestry

Assessing Svenska Cellulosa Aktiebolaget’s Valuation After 2025 Results And Leadership Change

Earnings and leadership change put SCA in focus Svenska Cellulosa Aktiebolaget (OM:SCA B) has reported full year 2025 results, proposed a SEK 3.00 per share dividend, and announced a leadership change in its Containerboard and Pulp operations. See our latest analysis for Svenska Cellulosa Aktiebolaget. Despite the latest 1 day share price return of 1.04% to SEK112.1, Svenska Cellulosa Aktiebolaget’s 1 year total shareholder return of 24.50% and 5 year total shareholder return of 17.48% show...